Why is Emcure Pharma falling/rising?

As of 12-Aug, Emcure Pharmaceuticals Ltd's stock is rising, with a current price of 1,400.85, reflecting an increase of 18.85 or 1.36%. The stock has outperformed its sector today by 0.98% and has shown consecutive gains over the last two days, accumulating a total return of 1.88% in that period. Despite a recent decline of 2.35% over the past week, the stock has performed well over the last month, gaining 7.99%. The company has demonstrated strong management efficiency with a high return on capital employed (ROCE) of 20.99% and has reported positive results for the last four consecutive quarters, which has contributed to its recent upward movement. However, there are concerns regarding long-term growth, as operating profit has only grown at an annual rate of 8.80% over the last five years, and institutional investor participation has decreased. In the broader market context, while the stock has generated a return of 9.93% over the past year, the benchmark Sensex has only returned 0.74%, indicating that Emcure Pharmaceuticals has outperformed the market significantly. The stock's recent performance contrasts with the negative returns of -2.11% from the broader BSE500 index over the same period. This suggests that despite some risks, such as falling institutional participation and expensive valuations, Emcure Pharmaceuticals is currently benefiting from strong operational performance and market conditions that favor its recent price increase.